People News: Alexion Pharmaceuticals and KV Pharmaceutical
Specialty firm KV Pharmaceutical named David Van Vliet CEO, with a term through December 31, 2011. Van Vliet has served as interim president and CEO since December 2008.
Sun Pharma's branded prostate cancer treatment Yonsa just received FDA approval.
Amgen and Novartis enlisted Arnold Worldwide, Wavemaker, and Starcom Media Group for its Speak Your Migraine campaign.
Novocure and Glue Advertising put on a Facebook Live event promoting the cancer treatment Optune in March.